Birgitte Bentz Damholt

Albumin‐bound basal insulin analogues (insulin detemir and NN344): comparable time‐action profiles but less variability than insulin glargine in type 2 diabetes

Oliver Klein, Jan Lynge, Lars Endahl et al. · Diabetes Obesity and Metabolism · 2006 · 252 citations

Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice

Yilmaz Emre Gençay, Camille Robert, Szabolcs Semsey et al. · Nature Biotechnology · 2023 · 210 citations · Full text

An Open‐Label, Parallel Group Study Investigating the Effects of Age and Gender on the Pharmacokinetics of the Once‐Daily Glucagon‐Like Peptide‐1 Analogue Liraglutide

Birgitte Bentz Damholt, Georg Golor, W Wierich et al. · The Journal of Clinical Pharmacology · 2006 · 78 citations

Aging, Elderly Subjects, Peptide Therapeutics +16

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Macimorelin in Children with Suspected Growth Hormone Deficiency: An Open-Label, Group Comparison, Dose-Escalation Trial

Violetta Csákváry, Nicola Ammer, Ekaterine Bakhtadze Bagci et al. · Hormone Research in Paediatrics · 2021 · 14 citations · Full text

Absorption, metabolism and excretion of once-weekly somapacitan, a long-acting growth hormone derivative, after single subcutaneous dosing in human subjects

Hans Helleberg, Mads Bjelke, Birgitte Bentz Damholt et al. · European Journal of Pharmaceutical Sciences · 2021 · 11 citations · Full text